Gloshell
Ingredients

Ingredient Dictionary

SORBITAN SESQUICAPRYLATE

Molecular structure

Definition

US FDA substance register · UNII V7P8VP00L4 · registered name SORBITAN SESQUICAPRYLATE · mixture

Source: US FDA Unique Ingredient Identifier (UNII)

Sorbitan Sesquicaprylate is a mixture of mono and diesters of Caprylic Acid and hexitol anhydrides derived from sorbitol

Cosmetic roles

Surfactant that lifts dirtSURFACTANT - CLEANSINGAdjusts thicknessVISCOSITY CONTROLLINGKeeps skin in good condition (CosIng catch-all)SKIN CONDITIONING

Safety & regulatory references

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

Other restriction: ban substances that deplete the ozone layer

Source: EU CosIng ingredient list

Reviewed by CIR: Safety Assessment of Sorbitan Esters as Used in Cosmetics

Source: US Cosmetic Ingredient Review (CIR)

More data — names, identifiers, properties, test records, literature

Official labels & definitions

JCIA labelling name セスキカプリル酸ソルビタン: 本品は、カプリル酸とソルビトール由来のヘキシトール無水物のモノ及びジエステルとの混合物である。

Source: JCIA labelling names (Japan)

Names & identifiers

SORBITAN SESQUICAPRYLATEINCI솔비탄세스퀴카프릴레이트Korean label name (MFDS standard)セスキカプリル酸ソルビタンJapanese labelling name
CAS No.chemical registry number
91844-53-0
EC No.EU chemical inventory number
295-118-4
DTXSIDUS EPA chemical ID
DTXSID70108269

What products actually use it for

What the 4 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Surfactant (surface active agent)2
  • Viscosity modifier1
  • Softener and conditioner1

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

2 skin studies and 1 eye studies are on record.

Classed as low2

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 3 studies
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to

Source: US EPA CompTox dashboard

Related literature

Linked databases 12